Arvee Laboratories India Q3 Results 2025 on 15 Feb, 2025: profit falls by 37.5% YOY, profit at ₹0.15 crore and revenue at ₹8.91 crore

Arvee Laboratories India Q3 Results 2025:Arvee Laboratories India declared their Q3 results on 12 Feb, 2025, reporting a revenue increase of 15.71% year-on-year but a concerning profit decline of 37.5%. The profit stood at ₹0.15 crore, while revenue reached ₹8.91 crore.

However, when compared to the previous quarter, the company faced significant challenges, with revenue declining by 28.89% and profit plummeting by 84.69%. This troubling trend raises questions about the sustainability of their current financial strategies.

Additionally, the Selling, General & Administrative expenses have risen, increasing by 4.46% quarter-on-quarter and by 19.39% year-on-year. This rise in expenses could further impact profitability if not managed effectively.

The operating income also showed a stark decrease, down by 94.17% quarter-on-quarter and 58.82% year-on-year, indicating a substantial contraction in operational performance.

Earnings per share (EPS) for Q3 is reported at ₹0.14, which represents a decrease of 36.36% year-on-year. This decline in EPS signals a potential decrease in investor confidence moving forward.

Arvee Laboratories India has delivered a return of -2.5% in the last week, -23.37% in the last six months, and a -16.4% return year-to-date, showcasing a troubling trend for investors.

Currently, Arvee Laboratories India holds a market capitalization of ₹153.29 crore, with a 52-week high of ₹315 and a low of ₹117.05. This volatility reflects the challenges the company faces in the competitive market.

Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.